Clinical Trial Update: Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial investigates whether modulating the skin microbiome can prevent radiation dermatitis in breast cancer patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Skin Microbiome, Breast Cancer | Phase 3 | Status: RECRUITING